EFFECTIVE HALF-LIFE OF I-131 IN THYROID CARCINOMA PATIENTS RECEIVING LOW-DOSE ABLATION THERAPY WITH RTSH

被引：0
|
作者：
Willowson, K. [1 ]
Bailey, D. [2 ]
Forwood, N. [2 ]
Bailey, E. [2 ]
Roach, P. [2 ]
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Royal N Shore Hosp, Dept Nucl Med, Sydney, NSW, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2012年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [41] LOW DOSE-RATE I-131 THERAPY FOR THYROID-CANCER
    SILVA, F
    FLORES, C
    ORDUNA, E
    ROSA, E
    GONZALEZ, R
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P165 - P165
  • [42] LOW-DOSE SODIUM IODIDE I-131 THERAPY IN GRAVES-DISEASE
    RAPOPORT, B
    CAPLAN, R
    DEGROOT, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 224 (12): : 1610 - 1613
  • [43] The Result of Multiple I-131 Treatments on the Effective Half-Life of Retained Radioactivity in Patients Ablated for Differentiated Thyroid Cancer: Possible Evidence for Thyroid Remnant Function Impairment
    Okkalides, Demetrios
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2016, 31 (02) : 58 - 64
  • [44] LOW IODINE DIET IN I-131 ABLATION OF THYROID REMNANTS
    MAXON, HR
    THOMAS, SR
    BOEHRINGER, A
    DRILLING, J
    SPERLING, MI
    SPARKS, JC
    CHEN, IW
    CLINICAL NUCLEAR MEDICINE, 1983, 8 (03) : 123 - 126
  • [45] Thyroid remnant ablation of differentiated thyroid carcinoma: a comparison of ablation success with high and low doses of radioiodine (I-131)
    Elrasad, S. A. A.
    Abdelhafeez, Y.
    Husseini, M. A.
    Amin, R. A. A.
    Elrefaei, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S328 - S328
  • [46] Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: A retrospective study
    Grenfell, Solveig
    Roos, Daniel
    Rijken, James
    Higgs, Braden
    Kirkwood, Ian
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (02) : 248 - 254
  • [47] Determining thyroid 131I effective half-life for the treatment planning of Graves' disease
    Willegaignon, Jose
    Sapienza, Marcelo T.
    Coura Filho, George Barberio
    Traino, Antonio C.
    Buchpiguel, Carlos A.
    MEDICAL PHYSICS, 2013, 40 (02)
  • [48] Comparing High and Low dose I-131 Therapy in Intermediate and Low Risk Differentiated Thyroid Cancer Patients
    Yasmin, T.
    Adnan, S.
    Younis, M. N.
    Shahid, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S664 - S665
  • [49] Characterization of thyroid cancer patients receiving additional I-131 therapy at post-ablation follow-up
    Bekker, A. C.
    Staanum, P. F.
    Morsing, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S464 - S465
  • [50] Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
    Lee, Jong Jin
    Chung, June-Key
    Kim, Sung Eun
    Kang, Won Jun
    Park, Do Joon
    Lee, Dong Soo
    Cho, Bo Youn
    Lee, Myung Chul
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (09) : 727 - 734
12345